Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuan Lei

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Acta Pharmaceutica Sinica. B|May 3, 2018
Biosynthesis of antibiotic chuangxinmycin from <i>Actinoplanes tsinanensis</i>Yuanyuan Shi, Zhibo Jiang, Xingxing Li, et al.
Journal of Biotechnology|February 21, 2017
Complete genome sequence of Amycolatopsis orientalis CPCC200066, the producer of norvancomycinXuan Lei, Cong Zhang, Zhibo Jiang, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 29, 2023
Quality markers of Guchang Zhixie pills based on multicomponent qualitative and quantitative analysis combined with network pharmacology and chemometric analysisYing Zhang, Qiong Qu, Xuan Lei, et al.
Journal of Ethnopharmacology|February 24, 2024
Sambucus williamsii Hance: A comprehensive review of traditional uses, processing specifications, botany, phytochemistry, pharmacology, toxicology, and pharmacokineticsXuan Lei, Ying Zhang, Xuan Wei, et al.
Inorganic Chemistry|February 10, 2026
One MOF with a New Type of Layer-Pillar Structure and Candy-like Cages for One-Step Purification of C<sub>2</sub>H<sub>4</sub> from C<sub>2</sub> HydrocarbonsJiao-Jing Jing, Yu-Xuan Lei, Lin Zhang, et al.
American Journal of Cancer Research|August 15, 2022
miR-1297 inhibits osteosarcoma cell proliferation and growth by targeting CCND2Pan Jiang, Lianghao Mao, Xuan Lei, et al.
Natural Product Communications|November 30, 2018
Exploiting Substrate Diversity of NRPS Led to the Generation of New Sansanmycin AnalogsShan-Shan Wang, Ning-Ning Zhang, Ning He, et al.
Microbial Cell Factories|May 8, 2016
Improving the N-terminal diversity of sansanmycin through mutasynthesisYuanyuan Shi, Zhibo Jiang, Xuan Lei, et al.
Expert Opinion on Therapeutic Patents|February 20, 2025
A patent review of CYP3A4 inhibitors (2018 - present)Dong-Zhu Tu, Xue-Yan Hu, Jing-Xuan Lei, et al.
Microbial Cell Factories|February 3, 2021
Comparative genomics and transcriptomics analyses provide insights into the high yield and regulatory mechanism of Norvancomycin biosynthesis in Amycolatopsis orientalis NCPC 2-48Xingxing Li, Cong Zhang, Ying Zhao, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Acta Pharmaceutica Sinica. B|May 3, 2018
Biosynthesis of antibiotic chuangxinmycin from <i>Actinoplanes tsinanensis</i>Yuanyuan Shi, Zhibo Jiang, Xingxing Li, et al.
Journal of Biotechnology|February 21, 2017
Complete genome sequence of Amycolatopsis orientalis CPCC200066, the producer of norvancomycinXuan Lei, Cong Zhang, Zhibo Jiang, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 29, 2023
Quality markers of Guchang Zhixie pills based on multicomponent qualitative and quantitative analysis combined with network pharmacology and chemometric analysisYing Zhang, Qiong Qu, Xuan Lei, et al.
Journal of Ethnopharmacology|February 24, 2024
Sambucus williamsii Hance: A comprehensive review of traditional uses, processing specifications, botany, phytochemistry, pharmacology, toxicology, and pharmacokineticsXuan Lei, Ying Zhang, Xuan Wei, et al.
Inorganic Chemistry|February 10, 2026
One MOF with a New Type of Layer-Pillar Structure and Candy-like Cages for One-Step Purification of C<sub>2</sub>H<sub>4</sub> from C<sub>2</sub> HydrocarbonsJiao-Jing Jing, Yu-Xuan Lei, Lin Zhang, et al.
American Journal of Cancer Research|August 15, 2022
miR-1297 inhibits osteosarcoma cell proliferation and growth by targeting CCND2Pan Jiang, Lianghao Mao, Xuan Lei, et al.
Natural Product Communications|November 30, 2018
Exploiting Substrate Diversity of NRPS Led to the Generation of New Sansanmycin AnalogsShan-Shan Wang, Ning-Ning Zhang, Ning He, et al.
Microbial Cell Factories|May 8, 2016
Improving the N-terminal diversity of sansanmycin through mutasynthesisYuanyuan Shi, Zhibo Jiang, Xuan Lei, et al.
Expert Opinion on Therapeutic Patents|February 20, 2025
A patent review of CYP3A4 inhibitors (2018 - present)Dong-Zhu Tu, Xue-Yan Hu, Jing-Xuan Lei, et al.
Microbial Cell Factories|February 3, 2021
Comparative genomics and transcriptomics analyses provide insights into the high yield and regulatory mechanism of Norvancomycin biosynthesis in Amycolatopsis orientalis NCPC 2-48Xingxing Li, Cong Zhang, Ying Zhao, et al.
Pageof 9